Lithium is a mood stabilizer used mainly to treat and prevent manic and depressive episodes in bipolar disorder. It reduces severity and frequency of mood swings and lowers suicide risk. It may augment antidepressants and treat schizoaffective disorder and certain headaches. Regular blood tests are needed to monitor lithium levels and kidney and thyroid function because of potential toxicity and side effects.

Lithium is a prescription mood stabilizer primarily used to treat and prevent manic and depressive episodes in bipolar disorder. It reduces relapse risk and lowers suicide risk. Lithium can also augment antidepressant therapy in some major depressive disorders and treat schizoaffective disorder. Regular blood tests and monitoring of kidney and thyroid function are required because of its narrow therapeutic range and potential side effects.

Yes. 'Li' is the chemical symbol and common short form for lithium. Clinically it denotes lithium salts such as lithium carbonate, used as a mood stabilizer in bipolar disorder. Lithium has a narrow therapeutic index, so plasma levels and kidney and thyroid function need regular monitoring. It also carries reproductive risks and requires caution in pregnancy and in patients with renal impairment.

Lithium’s chemical symbol is Li because element symbols use one or two letters from their English (or historic Latin) names, with the first letter capitalized and a second letter lowercase. The name “lithium” comes from the Greek lithos, meaning “stone,” reflecting its mineral origin; the naming convention assigned the distinctive two-letter symbol Li for the element.

The biggest side effect of lithium is potential kidney damage. Long-term use can cause nephrogenic diabetes insipidus (excessive urination and thirst) and progressive decline in renal function, sometimes leading to chronic kidney disease. Regular blood tests for kidney function and lithium levels, plus dose adjustments and careful hydration, are essential to minimize this risk.

Lithium can affect the kidneys. Short-term use commonly causes reduced urine concentration (nephrogenic diabetes insipidus) with polyuria and thirst. Long-term or high-level exposure may rarely lead to chronic kidney disease. Regular monitoring of serum creatinine/eGFR and lithium levels, dose adjustments, staying hydrated, and avoiding nephrotoxic drugs help reduce risk. Older age and prolonged treatment increase risk.